Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 12/30/2025
Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX
Osteoporosis International
Volume: 21
Date: 04 2010
Zoledronic acid treatment of osteoporosis: effects in men
Endocrine Practice
Volume: 16
Date: 10 2010
Management of osteoporosis in men on androgen deprivation therapy
Maturitas
Volume: 68
Date: 02 2011
Osteoporosis in men: the value of laboratory testing
Osteoporosis International
Volume: 22
Date: 06 2011
Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
Journal of Bone and Mineral Research
Volume: 26
Date: 09 2011
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis
Journal of the American Dental Association
Volume: 142
Date: 11 2011
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
Osteoporosis International
Volume: 23
Date: 01 2012
Osteoporosis in Men: an Endocrine Society Clinical Practice Guideline
Journal of Clinical Endocrinology and Metabolism
Volume: 97
Date: 05 2012
Duration of anti-resorptive therapy for osteoporosis
Endocrine
Volume: 51:222
Date: 01 2016
Managing osteoporosis in patients on long-term bisphosphonate treatment
Journal of Bone and Mineral Research
Volume: 31:16
Date: 01 2016